Kobayashi T, Kaneko S, Hara I, Park J Y, Aoki R, Ohno T, Nozawa S
Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo, Japan.
Arch Androl. 1991 Jul-Aug;27(1):55-60. doi: 10.3109/01485019108987652.
A cryosyringe and floating platform were developed to simplify the procedures for human sperm cryopreservation without sacrificing post-thaw sperm quality. The cryosyringe was developed as a vessel for cryopreservation and as a device for post-thaw insemination. A platform-like polystyrene foam board 3-cm in height was floated on the surface of liquid nitrogen in a polystyrene foam freezing container. The cryosyringe containing sperm/KS-II medium mixture was placed on it for 5 min, then it was dropped into the liquid nitrogen. Freezing velocity was -27 degrees C/min. Poor quality semen specimens (40 +/- 14 x 10(6)/ml, 18 +/- 2.6% motility, n = 9) were concentrated (87 +/- 46 x 10(6)/nl, 29 +/- 9.1%) previously and then cryopreserved in the cryosyringe or in a commercial tuberculin syringe under the conditions established in the present study. The post-thaw sperm motility of the specimens in the cryosyringe (18 +/- 7.4%) was significantly superior (p less than 0.05) to that in the commercial tuberculin syringe (13 +/- 5.3% motility).
开发了一种冷冻注射器和漂浮平台,以简化人类精子冷冻保存的程序,同时不降低解冻后精子的质量。冷冻注射器被开发为一种用于冷冻保存的容器以及解冻后授精的装置。一个高度为3厘米的平台状聚苯乙烯泡沫板漂浮在聚苯乙烯泡沫冷冻容器内的液氮表面。将装有精子/KS-II培养基混合物的冷冻注射器放置在上面5分钟,然后将其放入液氮中。冷冻速度为每分钟-27摄氏度。质量较差的精液标本(40±14×10⁶/ml,活力18±2.6%,n = 9)预先进行浓缩(87±46×10⁶/nl,29±9.1%),然后在本研究设定的条件下,在冷冻注射器或商用结核菌素注射器中进行冷冻保存。冷冻注射器中标本解冻后的精子活力(18±7.4%)显著优于(p<0.05)商用结核菌素注射器中的标本(活力13±5.3%)。